Tenet Healthcare Corporation $THC Shares Purchased by GDS Wealth Management

GDS Wealth Management lifted its holdings in Tenet Healthcare Corporation (NYSE:THC) by 6.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 80,075 shares of the company’s stock after purchasing an additional 4,956 shares during the quarter. GDS Wealth Management owned 0.09% of Tenet Healthcare worth $16,258,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of THC. AlphaQuest LLC lifted its position in Tenet Healthcare by 230.8% in the second quarter. AlphaQuest LLC now owns 1,763 shares of the company’s stock worth $310,000 after purchasing an additional 1,230 shares during the period. 111 Capital acquired a new stake in shares of Tenet Healthcare in the second quarter valued at $244,000. Cerity Partners LLC grew its holdings in Tenet Healthcare by 10.4% during the second quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after acquiring an additional 11,395 shares during the period. Campbell & CO Investment Adviser LLC acquired a new stake in Tenet Healthcare in the 3rd quarter valued at about $1,648,000. Finally, Goldentree Asset Management LP acquired a new position in shares of Tenet Healthcare in the 2nd quarter worth approximately $31,471,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on THC shares. Mizuho lifted their price target on shares of Tenet Healthcare from $194.00 to $225.00 and gave the stock an “outperform” rating in a research report on Friday, October 17th. Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, January 18th. UBS Group increased their price target on Tenet Healthcare from $238.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a report on Wednesday, January 7th. Finally, Guggenheim lifted their target price on shares of Tenet Healthcare from $238.00 to $257.00 and gave the stock a “buy” rating in a research report on Tuesday, December 2nd. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and an average price target of $233.81.

Insider Transactions at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 13,322 shares of Tenet Healthcare stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $205.11, for a total transaction of $2,732,475.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard W. Fisher sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, October 29th. The stock was sold at an average price of $208.43, for a total value of $521,075.00. Following the sale, the director directly owned 8,792 shares of the company’s stock, valued at $1,832,516.56. This trade represents a 22.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 45,500 shares of company stock valued at $9,247,071 in the last three months. 0.81% of the stock is currently owned by insiders.

Tenet Healthcare Price Performance

Shares of THC opened at $188.70 on Friday. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.64. The company has a market capitalization of $16.58 billion, a price-to-earnings ratio of 12.93, a P/E/G ratio of 0.80 and a beta of 1.41. The business’s 50-day moving average is $201.09 and its 200-day moving average is $191.49. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $222.82.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Tuesday, October 28th. The company reported $3.70 EPS for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The firm had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The firm’s revenue was up 3.2% on a year-over-year basis. During the same period in the previous year, the firm posted $2.93 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Equities research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.